Roc had quite a bit of European exposure, but most of that was chemtall and that is for export OUT of Germany. I'm gonna be focused on impact of fx....expecially with respect to roc. We hold at these levels, I'm probably buying.
another thing....the debt they're taking on to buy roc looking smart. I would think capital costs will come in below the pro forma they used.
We were invested in a great company with great upside and nice steady growth in stock price. Now that we were bought out and settled two weeks ago all the gains are gone. Thanks for nothing.
Company performance is very sensitive to US dollar strength.
"While the impact of foreign exchange on total company sales and earnings in 2014 was very modest, as we enter 2015, the steep depreciation of both the euro and the Japanese yen represent a major financial headwind. Our earnings are exposed to the movement of these 2 currencies versus the dollar. Specifically, on the combined company, we estimate that every $0.01 change in the euro-dollar exchange rate will have an impact of approximately $1.5 million to $2 million EBITDA. And every JPY 1 change in the yen-dollar exchange rate will have an EBITDA impact of approximately $0.5 million to $1 million. To put that in perspective, ranging the euro between $1.12 and $1.18, and the yen to between JPY 117 and JPY 121, we would expect to see a $40 million to $50 million headwind to EBITDA in 2015, or about $0.20 per share."